Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q4
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Epinephrine is one of the important hormones in the defense of hypoglycemia. We will test the
hypothesis that antecedent hypoglycemia will blunt the metabolic, neuroendocrine and
cardiovascular effects of subsequent epinephrine infusion in Type 1 DM.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center